TrialAntimicrobial agents and chemotherapy2023

Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers.

Michael R Hodges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.